Emerging Antifungal Targets and Strategies
Open accessThe DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Abstract
Despite abundant research in the field of antifungal drug discovery, fungal infections remain a significant healthcare burden. There is an emerging need for the development of novel antifungals since those currently available are limited and do not completely provide safe and secure protection. Since the current knowledge regarding the physiology of fungal cells and the infection mechanisms is greater than ever, we have the opportunity to use this for the development of novel generations of antifungals. In this review, we selected and summarized recent studies describing agents employing different antifungal mechanisms. These mechanisms include interference with fungal resistance, including impact on the efflux pumps and heat shock protein 90. Additionally, interference with virulence factors, such as biofilms and hyphae; the impact on fungal enzymes, metabolism, mitochondria, and cell wall; and antifungal vaccines are explored. The agents investigated belong to different classes of natural or synthetic molecules with significant attention given also to plant extracts. The efficacy of these antifungals has been studied mainly in vitro with some in vivo, and clinical studies are needed. Nevertheless, there is a large quantity of products employing novel antifungal mechanisms that can be further explored for the development of new generation of antifungals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was synthesized based on ToAP2 and exhibited antifungal activity against Sporothrix globosa with good serum stability and low toxicity (81).”
From Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review (2023) · cites this paper as [81]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Cell wall of fungus, being the outermost component of the cell, facilitates the initial physical interaction between microorganisms and their environment, including the host [19].”
From Mitochondrial anchor protein Num11 is key to pathogenicity of Candida albicans by affecting mitochondrial function and cell wall masking (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resistance of Candida to azoles and echinocandins worldwide
Pristov, K. E., & Ghannoum, M. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.028 · Cited by 706 · cited 1×
“The exact mechanism of resistance is linked with the mutation of two regions of the FKS1p subunit of β-(1,3) d-glucan synthase, which subsequently leads to the substitution of serine 645 for proline, phenylalanine, and tyrosine and changes the echinocandins target site [40].”
BackgroundStone, N. R. H., Bicanic, T., Salim, R., & Hope, W. (2016) · Drugs · doi:10.1007/s40265-016-0538-7 · Cited by 537 · cited 2×
“However, due to recorded significant dose-limiting toxicity of this formulation, mainly nephrotoxicity and infusion-related reactions, less toxic formulations were developed [27].”
BackgroundAmphotericin forms an extramembranous and fungicidal sterol sponge
Anderson, T. M., Clay, M. C., Cioffi, A. G., Diaz, K. A., Hisao, G. S., Tuttle, M. D., Nieuwkoop, A. J., Comellas, G., Maryum, N., Wang, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1496 · Cited by 528 · cited 2×
“It is proposed that extraction of the essential cell lipid underlies the antifungal action of this compound [26].”
BackgroundCampoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 416 · cited 1×
“Mechanisms of antifungal resistance include decrease of effective drug concentration, drug target alterations, and metabolic bypasses [48].”
BackgroundSpampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411 · cited 1×
“Additionally, point mutations in ERG3 can inactivate C5 sterol desaturase leading to alterations in the ergosterol synthetic pathway and inducing azole resistance [15].”
BackgroundCavassin, F. B., Baú-Carneiro, J. L., Vilas-Boas, R. R., & Queiroz-Telles, F. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00382-7 · Cited by 382
Lemke, A., Kiderlen, A. F., & Kayser, O. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1955-9 · Cited by 305
Candida Species Biofilms’ Antifungal Resistance
Silva, S., Rodrigues, C., Araújo, D., Rodrigues, M., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 302
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Flowers, S. A., Colón, B., Whaley, S. G., Schuler, M. A., & Rogers, P. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03470-14 · Cited by 294 · cited 1×
“Mutations in ERG11 are frequent among azole-resistant clinical fungal strains [103].”
Background
Cited by
Yassin, M. T., Mostafa, A. A.-F., Al-Askar, A. A., & Al-Otibi, F. O. (2022) · Crystals · doi:10.3390/cryst12060774 · Cited by 96
Recent Advances in the Allergic Cross-Reactivity between Fungi and Foods
Xing, H., Wang, J., Sun, Y., & Wang, H. (2022) · Journal of Immunology Research · doi:10.1155/2022/7583400 · Cited by 92
Zhang, C.-W., Zhong, X., Zhao, Y.-S., Rajoka, M. S. R., Hashmi, M. H., Zhai, P. C., & Song, X. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100262 · Cited by 72
Fish Skin Mucus Extracts: An Underexplored Source of Antimicrobial Agents
Díaz‐Puertas, R., Adamek, M., Mallavia, R. M., & Falcó, A. (2023) · Marine Drugs · doi:10.3390/md21060350 · Cited by 59
“This situation is substantially worsened by the long-lasting drought (with a few recent exceptions [4]) in the discovery of new classes of antibiotics since 1962 [1,5] and the continued scarcity and specificity of antifungals [6] and antivirals [7].”
BackgroundInfluentialRecent drug development and treatments for fungal infections
Roy, M., Karhana, S., Shamsuzzaman, M., & Khan, M. A. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-00999-z · Cited by 51
“Terbinafine, when applied topically, causes adverse events like gastrointestinal disturbance, erythema, urticaria, rashes, neutropenia, and musculoskeletal reactions [46].”
Background
Metadata
- Authors
- Ivanov, M., Ćirić, A., & Stojković, D.
- Affiliations
- University of Belgrade (RS)
- Corresponding author
- Ivanov, Marija
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-03-02
- Volume
- 23
- Issue
- 5
- Pages
- 2756
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8911111
- OpenAlex
- W4214877855
- Cited by
- 160
- References
- 154
- Citations by year
- 2026: 31 · 2025: 46 · 2024: 36 · 2023: 35 · 2022: 12
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministarstvo prosvete, nauke i tehnoloskog razvoja (451-03-9/2021–14/200007)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- antifungal drug discovery, antifungal drug targets, fungal infection, efflux pumps, HSP90, fungal virulence factors, biofilm, fungal hyphae, fungal enzymes, fungal metabolism, mitochondria, cell wall, antifungal vaccines, plant extracts, natural products, synthetic compounds, drug resistance
- MeSH terms
- Antifungal Agents, Cell Wall, Humans, Mycoses, Biofilms, Drug Resistance, Fungal, Hyphae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging Antifungal Targets and Strategies. https://app.cochat.ai/papers/10.3390/ijms23052756
- The paper
- Ivanov, M., Ćirić, A., & Stojković, D. (2022). Emerging Antifungal Targets and Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23052756
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.